Gland Pharma Ltd appoints Ajay Sahni as President of Phixen SAS, effective November 30, 2026
- Sahni succeeds Alain Kirchmeyer following his appointment by Phixen SAS’s Supervisory Board.
- He currently leads Gland Pharma International Pte. Ltd. and is responsible for the Cenexi business.
- Sahni will report to Gland Pharma’s CEO.
